1. HIV-1 Balances the Fitness Costs and Benefits of Disrupting the Host Cell Actin Cytoskeleton Early after Mucosal Transmission.
- Author
-
Usmani SM, Murooka TT, Deruaz M, Koh WH, Sharaf RR, Di Pilato M, Power KA, Lopez P, Hnatiuk R, Vrbanac VD, Tager AM, Allen TM, Luster AD, and Mempel TR
- Subjects
- Actins metabolism, Animals, Chemokines metabolism, Disease Models, Animal, Female, HEK293 Cells, HIV Infections immunology, HIV Infections virology, HIV-1 immunology, Human Immunodeficiency Virus Proteins metabolism, Humans, Lymphocytes virology, Mice, Mucous Membrane virology, T-Lymphocytes immunology, T-Lymphocytes virology, Viral Regulatory and Accessory Proteins metabolism, Viremia, nef Gene Products, Human Immunodeficiency Virus immunology, nef Gene Products, Human Immunodeficiency Virus metabolism, p21-Activated Kinases metabolism, Actin Cytoskeleton metabolism, Cell Movement, HIV Infections transmission, HIV-1 pathogenicity, HIV-1 physiology, Mucous Membrane metabolism
- Abstract
HIV-1 primarily infects T lymphocytes and uses these motile cells as migratory vehicles for effective dissemination in the host. Paradoxically, the virus at the same time disrupts multiple cellular processes underlying lymphocyte motility, seemingly counterproductive to rapid systemic infection. Here we show by intravital microscopy in humanized mice that perturbation of the actin cytoskeleton via the lentiviral protein Nef, and not changes to chemokine receptor expression or function, is the dominant cause of dysregulated infected T cell motility in lymphoid tissue by preventing stable cellular polarization required for fast migration. Accordingly, disrupting the Nef hydrophobic patch that facilitates actin cytoskeletal perturbation initially accelerates systemic viral dissemination after female genital transmission. However, the same feature of Nef was subsequently critical for viral persistence in immune-competent hosts. Therefore, a highly conserved activity of lentiviral Nef proteins has dual effects and imposes both fitness costs and benefits on the virus at different stages of infection., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF